Black Rock Inc. Summit Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,823,341 shares of SMMT stock, worth $76.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,823,341
Previous 9,759,383
0.66%
Holding current value
$76.6 Million
Previous $25.5 Million
59.66%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SMMT
# of Institutions
107Shares Held
41.3MCall Options Held
103KPut Options Held
29.9K-
State Street Corp Boston, MA8.11MShares$63.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.27MShares$56.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.15MShares$24.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.07MShares$8.37 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA1.02MShares$7.93 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $1.57B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...